Phibro Animal Health (PAHC) Cash from Operations Growth (3y) (2016 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Cash from Operations Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn | 20.12% |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn | 52.97% |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | 65.60% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 5.99% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -113.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.99% |
| Mar 31, 2026 | 37.32% |
| Dec 31, 2025 | 113.82% |
| Sep 30, 2025 | 42.10% |
| Jun 30, 2025 | 138.20% |
| Mar 31, 2025 | 91.63% |
| Dec 31, 2024 | -46.53% |
| Sep 30, 2024 | 48.93% |
| Jun 30, 2024 | 109.99% |
| Mar 31, 2024 | -11.80% |
| Dec 31, 2023 | 5.45% |
| Sep 30, 2023 | 112.09% |
| Jun 30, 2023 | 73.47% |
| Mar 31, 2023 | -38.53% |
| Dec 31, 2022 | -27.60% |
| Sep 30, 2022 | -44.17% |
| Jun 30, 2022 | -52.71% |
| Mar 31, 2022 | -26.83% |
| Dec 31, 2021 | 9.43% |
| Sep 30, 2021 | 43.99% |